We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

Single Cell Analysis with the BD AbSeq Assay

Single Cell Analysis with the BD AbSeq Assay

Blog

New tools are enabling researchers to explore individual cells with unprecedented clarity, allowing RNA and protein expression levels to be simultaneously analyzed. In this blog, Brian Lilhanand, Global Platform Leader, Single Cell Multiomics, at BD, discusses how BD’s new AbSeq Assay can provide this targeted profiling and benefit immunology researchers.





Read More

A Move Towards Precise Management of Bacterial Infections

A Move Towards Precise Management of Bacterial Infections

Blog

Following the recent FDA approval of a procalcitonin assay, we spoke with a representative from Fujirebio Diagnostics, Inc. to learn how measuring this important biomarker will improve the healthcare landscape.

Read More

Determining Prognostic Significance of Biomarkers for Risk Stratification of Early Stage Lung Cancer

Determining Prognostic Significance of Biomarkers for Risk Stratification of Early Stage Lung Cancer

Blog

During this year’s AACR Annual Meeting we spoke to Dr. Delphine Lissa and Dr. Ana Robles from the National Cancer Institute to learn more about the team’s most recent study on the use of two specific biomarkers for risk stratification of stage I lung cancer patients.

Read More

Accelerating Proteome Analysis With PASEF: A Unique and Sensitive Technique

Accelerating Proteome Analysis With PASEF: A Unique and Sensitive Technique

Blog

Understanding the proteome is a fundamental challenge of biology. Here, Bruker Daltonics' Gary Kruppa and Scarlet Koch outline a new method, Parallel Accumulation Serial Fragmentation (PASEF) that offers faster, more sensitive and more robust proteome analysis, giving scientists the potential to discover low-level, biologically significant proteins and validate them in research.

Read More

How Native MS and Charge Algorithms Can Improve Protein Analysis

How Native MS and Charge Algorithms Can Improve Protein Analysis

Blog

Native Mass Spectrometry (MS) can be used to examine proteins in their natural, folded forms. In this blog, Marshall Bern, Ph.D., the Vice President of Research and Co-Founder of Protein Metrics, discusses how advances in this technique are being paired with cutting-edge charge deconvolution algorithms to improve analysis of antibodies and plasma glycoproteins.

Read More

A New Generation of Flow Cytometers Advances Multiomics

A New Generation of Flow Cytometers Advances Multiomics

Blog

Flow cytometry allows the analysis of physical and biochemical features of cells. Advances in machine that can characterize and sort cells will allow researchers to look deeper than ever before into the proteome and transcriptome. We talk with Bob Balderas, VP Market Development at BD on how the cutting-edge machines like the FACSymphony S6 cell sorter incorporate new technology and advance multiomics research.

Read More

Newly Discovered Biomarker Could Help Diagnose Hearing Loss Earlier

Newly Discovered Biomarker Could Help Diagnose Hearing Loss Earlier

Blog

In collaboration with UConn, Sensorion have identified the first potential biomarker for noise-induced hearing loss, findings which were recently presented at the 53rd American Neurotology Society Annual Spring Meeting.

Read More

Cinderella and Mass Spectrometry: Insightful Multi-Dimensional Data Analysis

Cinderella and Mass Spectrometry: Insightful Multi-Dimensional Data Analysis

Blog

Proteomics is a powerful technology for analyzing low-abundance proteins for disease research. But it’s stalled by imprecise and often irreproducible data analysis. Here, David Chiang, Founder of Sage-N Research, explains how his company uses multidimensional separation to improve peptide identification in MS/MS.

Read More

Data-Independent Acquisition: A Superior Technique in Mass Spectrometry?

Data-Independent Acquisition: A Superior Technique in Mass Spectrometry?

Blog

Whilst Mass Spectrometry is undoubted in its status as a central part of the proteomics toolkit, there is still debate about the way that MS data should be acquired and analyzed. Here, we talk to Florian Marty, Director Global Product Support at Biognosys AG, about why he believes that data-independent acquisition is a superior acquisition technique.

Read More

New Method to Rule out Early Stage Lung Cancer

New Method to Rule out Early Stage Lung Cancer

Blog

We spoke to Dr Albert Luderer, CEO of Integrated Diagnostics to learn about the challenges of diagnosing lung nodules as benign or malignant, and how the Xpresys Lung 2 liquid biopsy test can help improve this process.

Read More